Literature DB >> 30057450

Clinical Features of Cancer Associated Ischemic Stroke.

Nilüfer Yeşilot1, Esme Ekizoğlu1, Oğuzhan Çoban1.   

Abstract

INTRODUCTION: Cerebrovascular disease is the second most common cause of central nervous system involvement in cancer patients after metastases. Procoagulant substances secreted by tumour cells, cancer therapy, and embolus from tumour have been implicated in ischemic stroke (IS) in cancer patients.
METHODS: Four thousand twenty patients with IS were prospectively recorded to the Istanbul Medical School Stroke Registry from August 1997 to May 2016. Ninety-two patients with IS and cancer and 3928 IS patients without cancer constituted the two groups.
RESULTS: Hypertension, hyperlipidemia, and congestive heart failure were less commonly encountered in cancer stroke patients. Lacunar and posterior circulation syndromes were less common and total anterior circulation syndrome was more common in cancer patients (p<0.001). Multiple territory infarcts were more frequently seen in patients having overt or non-overt disseminated intravascular coagulopathy (DIC) compared to those without DIC. Median survival was significantly shorter in patients with cancer-related stroke.
CONCLUSION: Cancer associated stroke without other underlying etiology is a specific group of stroke patients presenting with multiple territorial infarcts, overt or non-overt disseminated intravascular coagulopathy, and poor prognosis.

Entities:  

Keywords:  Cancer; ischemic stroke

Year:  2018        PMID: 30057450      PMCID: PMC6060663          DOI: 10.29399/npa.22999

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  15 in total

1.  Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.

Authors:  F B Taylor; C H Toh; W K Hoots; H Wada; M Levi
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

2.  Stroke as the first manifestation of concealed cancer.

Authors:  Hyung-Min Kwon; Bong Su Kang; Byung-Woo Yoon
Journal:  J Neurol Sci       Date:  2007-04-03       Impact factor: 3.181

3.  Risk factor, pattern, etiology and outcome in ischemic stroke patients with cancer: a nested case-control study.

Authors:  Yun Yun Zhang; Dennis Cordato; Qing Shen; Ai Zhen Sheng; Wai Tak Hung; Daniel K Y Chan
Journal:  Cerebrovasc Dis       Date:  2006-12-01       Impact factor: 2.762

4.  Cancer in young adults with ischemic stroke.

Authors:  Karoliina Aarnio; Heikki Joensuu; Elena Haapaniemi; Susanna Melkas; Markku Kaste; Turgut Tatlisumak; Jukka Putaala
Journal:  Stroke       Date:  2015-04-28       Impact factor: 7.914

5.  Clinical and Neuroimaging Features of Acute Ischemic Stroke in Cancer Patients.

Authors:  Binbin Sun; Shuangyi Fan; Zhifang Li; Wanshen Guo; Lixue Liu; Youping Zhou; Luyan Ji; Leshi Zhang; Xusheng Huang
Journal:  Eur Neurol       Date:  2016-06-15       Impact factor: 1.710

6.  Microvesicle-associated tissue factor and Trousseau's syndrome.

Authors:  I Del Conde; L D Bharwani; D J Dietzen; U Pendurthi; P Thiagarajan; J A López
Journal:  J Thromb Haemost       Date:  2007-01       Impact factor: 5.824

7.  A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke.

Authors:  J Bamford; P Sandercock; M Dennis; C Warlow; L Jones; K McPherson; M Vessey; G Fowler; A Molyneux; T Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-11       Impact factor: 10.154

8.  Cryptogenic subtype predicts reduced survival among cancer patients with ischemic stroke.

Authors:  Babak B Navi; Samuel Singer; Alexander E Merkler; Natalie T Cheng; Jacqueline B Stone; Hooman Kamel; Costantino Iadecola; Mitchell S V Elkind; Lisa M DeAngelis
Journal:  Stroke       Date:  2014-07-03       Impact factor: 7.914

Review 9.  Stroke and cancer: a review.

Authors:  W Grisold; S Oberndorfer; W Struhal
Journal:  Acta Neurol Scand       Date:  2009-01       Impact factor: 3.209

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  1 in total

1.  Importance of Standard Treatment in Prognosis of Patients with Ovarian Cancer and Associated Cerebral Infarction.

Authors:  Zhen Yuan; Dongyan Cao; Mei Yu; Huimei Zhou; Ying Zhang; Jiaxin Yang; Keng Shen
Journal:  Clin Interv Aging       Date:  2020-02-05       Impact factor: 4.458

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.